GuangzhouMay 18, 2026 /PRNewswire/ — Recently, the Guangzhou Municipal Bureau of Industry and Information Technology officially announced the “First Batch of Chain Leader Enterprises and Promotion Institutions for Guangzhou’s Strategic Industrial Clusters.” Leveraging its leading technological strength in the gene delivery field and its core hub role in the industrial chain, Yunzhou Biosciences was successfully selected, becoming one of the first batch of chain leader enterprises in the cell and gene sector of Guangzhou’s biomedical and health strategic industrial cluster.
List of First Batch of Chain Leader Enterprises for Guangzhou’s Strategic Industrial Clusters (Excerpt)
Anchoring Future Industries, Building World-Class Industrial Clusters
The cell and gene industry is a core strategic track for Guangzhou to look toward the future and seize a competitive edge globally. In Guangzhou’s “12218” modern industrial system, this field is listed as one of the six major future industry directions for key development.
Centered on this strategic layout, Guangzhou continues to strengthen systematic policy supply and institutional innovation, coordinating efforts across multiple dimensions including legislative guarantees, special policies, and industrial ecosystem construction. Notably, in early 2026, Guangzhou initiated the legislative process for the “Guangzhou Cell and Gene Industry High-Quality Development Promotion Regulations,” aiming to establish a stable and predictable industrial development environment through local legislation. Additionally, the Guangzhou Development Zone launched the “Biomedical 3.0” policy system, providing systematic support in areas such as technological innovation, achievement transformation, clinical application, and industrial ecosystem development.
It is under this strategic framework that Guangzhou is focusing on building a chain leader enterprise system, using leading enterprises as engines to drive the overall upgrade of the cell and gene industry chain, accelerate technological innovation and achievement transformation, continuously enhance industrial agglomeration and international competitiveness, and strive to create a globally influential innovation hub for the cell and gene industry.
Leveraging the Role of Chain Leaders, Guiding Industrial Collaborative Development
According to the “Guangzhou Strategic Industrial Cluster Chain Leader Enterprises and Promotion Institutions Cultivation and Support Measures,” a “chain leader enterprise” refers to an enterprise that holds a core advantageous position in the industrial chain and supply chain, has a leading and driving role in the industry chain, exerts significant influence on optimizing resource allocation, technological product innovation, and industrial ecosystem construction, and has the capability and willingness to play a key role in enhancing the stability and competitiveness of Guangzhou’s industrial chain and supply chain, as well as in strengthening and expanding the industrial system.
As organizers and promoters of the industry chain, chain leader enterprises not only represent the leading level of industry development but also bear important responsibilities such as tackling key technologies, coordinating resource allocation, cultivating the industrial ecosystem, and ensuring supply chain stability. By integrating technology, capital, talent, and market resources, chain leader enterprises can drive the collaborative development of upstream and downstream enterprises, promote the overall upgrade of the industry chain, and enhance the independent innovation capability and international competitiveness of the regional industry.
Empowering Innovation in the Cell and Gene Therapy Industry
Yunzhou Biosciences is a global leader in the gene delivery field, deeply rooted in the industry for over a decade, and has built a full-chain service system for gene delivery covering everything from basic research to commercial production. The company’s proprietary VectorBuilder platform has disrupted the inefficient traditional model of DIY vector construction in laboratories, ushering in the era of commercialized custom gene vectors.
Currently, Yunzhou Biosciences has grown into an international enterprise with over ten subsidiaries and offices worldwide, serving a network covering more than 130 countries and regions. It has served over 7,000 research institutions and pharmaceutical companies, encompassing the vast majority of globally renowned research institutes and biomedical companies.
In the cell and gene therapy industry chain, gene delivery technology is a key underlying technology that determines R&D efficiency, product performance, and industrialization feasibility. As a key infrastructure enterprise connecting basic research, drug development, clinical translation, and commercial production, Yunzhou Biosciences plays a critical bridging role in the industry chain, continuously providing core technical support for the development of innovative therapies worldwide.
Open Collaborative Innovation, Building an Industrial Ecosystem Hub
As one of the first batch of chain leader enterprises in Guangzhou’s cell and gene field, Yunzhou Biosciences will actively assume the responsibility of industrial leadership, fully leveraging its advantages in technological innovation, global resource integration, and industrial collaboration to promote the high-quality development of the cell and gene industry.
The company will adopt a dual-drive mechanism of a “Chain Leader Office + Industry Alliance,” collaborating with research institutions, medical organizations, investment institutions, and upstream and downstream enterprises to create an open and efficient collaborative innovation platform.
On the technology front, it will promote joint efforts in tackling key core technologies and transforming achievements. On the industrial front, it will facilitate the construction of local supply chains and the connection of upstream and downstream resources. On the financial front, it will support innovative enterprises in addressing financing needs at critical stages. On the international cooperation front, it will actively introduce high-quality projects and innovative resources from home and abroad, accelerating the agglomeration and development of Guangzhou’s cell and gene industry.
Taking this selection as a chain leader enterprise as an opportunity, Yunzhou Biosciences will further deepen technological innovation, strengthen international cooperation, and expand the industrial ecosystem. It will join forces with all parties in the industry to jointly propel Guangzhou’s cell and gene field to a higher level, contributing core strength to building a world-class cell and gene industrial cluster.